Eli Lilly's New Drug Studies

Investing.com – Eli Lilly (NYSE:LLY) CEO David Ricks announced that the company will test obesity drugs for treating smoking and alcohol abuse, according to Bloomberg.

Ricks mentioned that the studies on addiction are set to begin in 2025.